Pioglitazone As a Potential Disease Modifying Therapy in Early Parkinson's Disease

被引：0
|
作者：
机构：
来源：
ANNALS OF NEUROLOGY | 2014年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S453 WIP
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [41] Preclinical Characterization of MIN-301, a Neuregulin-1 Fragment, as a Potential Disease-Modifying Therapy for Parkinson's Disease
    Noel, Nadine
    Werner, Sandra
    Lowe, David
    Detke, Michael
    Luthringer, Remy
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S529 - S530
  • [42] Statins as potential disease-modifying therapy of Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis
    Goncalves, Ocilio Ribeiro
    Nascimento, Arquimedes Barros
    Soares, Victor Goncalves
    Abraham, David
    Monteiro, Gabriel de Almeida
    Freitas, Joao Luis Reis
    Ribeiro, Jonatas Paulino da Cunha Monteiro
    Ribeiro, Bianca Leal
    de Oliveira, Joao Victor Araujo
    dos Santos, Marco Antonnio Rocha
    Telles, Joao Paulo Mota
    Sekeff-Sallem, Flavio
    Almeida, Kelson James
    ACTA NEUROLOGICA BELGICA, 2024,
  • [43] Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology
    Maclagan, Laura C.
    Visanji, Naomi P.
    Cheng Yi
    Tadrous, Mina
    Lacoste, Alix M. B.
    Kalia, Lorraine V.
    Bronskill, Susan E.
    Marras, Connie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (08) : 864 - 872
  • [44] In silico predictive analytics: accelerating identification of potential disease-modifying compounds for Parkinson's disease
    Visanji, N.
    Lactoste, A.
    Spangler, S.
    Argentinis, E.
    Ezell, S.
    Marras, C.
    Kalia, L.
    MOVEMENT DISORDERS, 2017, 32
  • [45] Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?
    Kansara, Sagar
    Trivedi, Akash
    Chen, Sheng
    Jankovic, Joseph
    Le, Weidong
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (01) : 197 - 210
  • [46] Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
    Sagar Kansara
    Akash Trivedi
    Sheng Chen
    Joseph Jankovic
    Weidong Le
    Journal of Neural Transmission, 2013, 120 : 197 - 210
  • [47] Sural Nerve Grafting as a Cell-based Disease-modifying Therapy for Parkinson's Disease
    El Seblani, N.
    Welleford, A. S.
    Quintero, J. E.
    Pomerleau, F.
    Huettl, P.
    Van Horne, C. G.
    Gerhardt, G. A.
    CELL TRANSPLANTATION, 2019, 28 (04) : 468 - 468
  • [48] The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson's Disease
    Neha
    Mazahir, Iqra
    Khan, Sara Akhtar
    Kaushik, Pooja
    Parvez, Suhel
    MOLECULAR NEUROBIOLOGY, 2024, 61 (10) : 8086 - 8103
  • [49] Defining Disease Modifying Therapy for Alzheimer's Disease
    Cummings, J.
    Fox, N.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2017, 4 (02): : 109 - 115
  • [50] Montelukast as Disease Modifying Treatment for Parkinson's Disease: A Pilot Study
    Wallin, J.
    Svenningsson, P.
    MOVEMENT DISORDERS, 2023, 38 : S58 - S59
12345